InVera Medical Receives FDA Clearance for InVera Infusion Device – a Novel Non-Thermal Catheter for Enhanced Infusion of Sclerosant for Chronic Venous Disease
Encouraging 12-month pilot clinical study results will be presented by Key Opinion Leader Dr. Lowell Kabnick at the prestigious Charing Cross Vascular Symposium... Read more.
Generac and CPower Expand Access to DER Technologies to Support Resiliency, Energy Costs and Grid Capacity
The collaboration combines Generac’s industry-leading DER solutions platform with CPower’s industry-leading VPP/DR services, creating a first-to-market... Read more.
XLA Names James Vant as Chief Executive Officer
VIENNA, Va., April 7, 2026 /PRNewswire/ — XLA, a leading provider of cybersecurity, data management and analytics, technical solutions, and international program-support... Read more.
When Every Beat Matters, BD Helps Clinicians Eliminate Blind Spots with Continuous, Noninvasive Blood Pressure Insight
New HemoSphere Stream™ Module expands access to continuous, noninvasive arterial waveform data across compatible bedside monitors and broader care settings, giving... Read more.
MEXC Lists Two Ondo Tokenized Stock Trading Pairs Tied to Quantum Computing Sector
VICTORIA, Seychelles, April 7, 2026 /PRNewswire/ — MEXC, the world leader in 0‑fee digital asset trading, has listed two Ondo tokenized stock trading pairs... Read more.
SASOL FINANCING USA LLC ANNOUNCES RESULTS OF CASH TENDER OFFER FOR ANY AND ALL OUTSTANDING DEBT SECURITIES
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON RESIDENT AND/OR LOCATED IN, ANY JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION... Read more.
GridBank Closes Oversubscribed $6M Seed Round to Build the Global Transaction Network for Real-World Data
Financing led by StandUp Ventures, co-led by Version One Ventures and GreenSky Ventures, with participation from Anges Québec Capital and Anges Québec MONTREAL,... Read more.
BlueAlly Appoints Sean Robertson as Senior Vice President of Federal
Federal market veteran joins BlueAlly as the company expands its focus on serving public sector clients with deep technical expertise, strong supplier relationships,... Read more.
Nuvalent Announces Submission of New Drug Application to FDA for Neladalkib in TKI Pre-treated Advanced ALK-positive NSCLC
New Drug Application (NDA) based on data in TKI pre-treated patients from the global ALKOVE-1 Phase 1/2 clinical trial CAMBRIDGE, Mass., April 7, 2026 /PRNewswire/... Read more.
Rocket 1.0 Solves What Vibe Coding Left Out: What to Build and What Comes After Launch
Rocket introduces Vibe Solutioning as the next evolution of Vibe Coding — bringing together strategic research, production-grade app building, and continuous competitive... Read more.